Home Aldehydes 1305207-52-6
1305207-52-6,MFCD21604173
Catalog No.:AA000UGU

1305207-52-6 | Oxetane-3-carbaldehyde

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
in stock  
$35.00   $25.00
- +
250mg
98%
in stock  
$43.00   $30.00
- +
1g
95%
in stock  
$115.00   $81.00
- +
5g
95%
in stock  
$485.00   $340.00
- +
10g
95%
in stock  
$894.00   $626.00
- +
25g
95%
in stock  
$2,058.00   $1,440.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000UGU
Chemical Name:
Oxetane-3-carbaldehyde
CAS Number:
1305207-52-6
Molecular Formula:
C4H6O2
Molecular Weight:
86.0892
MDL Number:
MFCD21604173
SMILES:
O=CC1COC1
Properties
Computed Properties
 
Complexity:
56.6  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
6  
Hydrogen Bond Acceptor Count:
2  
Rotatable Bond Count:
1  
XLogP3:
-0.7  

Downstream Synthesis Route

[1]CurrentPatentAssignee:SAGIMETBIOSCIENCESINC.-WO2014/8197,2014,A1Locationinpatent:Page/Pagecolumn207;208

[2]CurrentPatentAssignee:SAGIMETBIOSCIENCESINC.-WO2015/95767,2015,A1Locationinpatent:Page/Pagecolumn222;223

[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2015/54103,2015,A1Locationinpatent:Page/Pagecolumn33

[2]CurrentPatentAssignee:SAGIMETBIOSCIENCESINC.-WO2014/8197,2014,A1Locationinpatent:Page/Pagecolumn207;208

[3]CurrentPatentAssignee:KRONOSBIOINC-US2015/175616,2015,A1Locationinpatent:Paragraph0283;0284

[4]CurrentPatentAssignee:SAGIMETBIOSCIENCESINC.-WO2015/95767,2015,A1Locationinpatent:Page/Pagecolumn222;223

[5]CurrentPatentAssignee:KRONOSBIOINC-WO2015/100217,2015,A1Locationinpatent:Page/Pagecolumn118;119

[6]CurrentPatentAssignee:PFIZERINC-US2015/361067,2015,A1Locationinpatent:Paragraph0599

[7]CurrentPatentAssignee:KRONOSBIOINC-WO2016/10809,2016,A1Locationinpatent:Paragraph0307

[8]CurrentPatentAssignee:YUMANITYTHERAPEUTICSINC-WO2016/105485,2016,A2Locationinpatent:Paragraph0211

[9]Degnan,AndrewP.;Maxwell,Darrell;Balakrishnan,Anand;Brown,JeffreyM.;Easton,Amy;Gulianello,Michael;Hanumegowda,Umesh;Hill-Drzewi,Melissa;Miller,Regina;Santone,KennethS.;Senapati,Arun;Shields,EricE.;Sivarao,DigavalliV.;Westphal,Ryan;Whiterock,ValerieJ.;Zhuo,Xiaoliang;Bronson,JoanneJ.;Macor,JohnE.[BioorganicandMedicinalChemistryLetters,2016,vol.26,#24,p.5871-5876]

[10]CurrentPatentAssignee:KRONOSBIOINC-WO2016/172117,2016,A1Locationinpatent:Page/Pagecolumn48

[11]CurrentPatentAssignee:YUMANITYTHERAPEUTICSINC-WO2017/19589,2017,A1Locationinpatent:Paragraph0185

[12]CurrentPatentAssignee:YUMANITYTHERAPEUTICSINC-WO2017/112853,2017,A1Locationinpatent:Paragraph0185

[13]Kung,Pei-Pei;Bingham,Patrick;Brooun,Alexei;Collins,Michael;Deng,Ya-Li;Dinh,Dac;Fan,Connie;Gajiwala,KetanS.;Grantner,Rita;Gukasyan,HovhannesJ.;Hu,Wenyue;Huang,Buwen;Kania,Robert;Kephart,SusanE.;Krivacic,Cody;Kumpf,RobertA.;Khamphavong,Penney;Kraus,Manfred;Liu,Wei;Maegley,KarenA.;Nguyen,Lisa;Ren,Shijian;Richter,Dan;Rollins,RobertA.;Sach,Neal;Sharma,Shikhar;Sherrill,John;Spangler,Jillian;Stewart,AlbertE.;Sutton,Scott;Uryu,Sean;Verhelle,Dominique;Wang,Hui;Wang,Shuiwang;Wythes,Martin;Xin,Shuibo;Yamazaki,Shinji;Zhu,Huichun;Zhu,Jinjiang;Zehnder,Luke;Edwards,Martin[JournalofMedicinalChemistry,2018,vol.61,#3,p.650-665]

[14]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.-US2018/265517,2018,A1Locationinpatent:Paragraph0366-0368

[15]CurrentPatentAssignee:CYTOKINETICSINC;AMGENINC-US2019/77793,2019,A1Locationinpatent:Paragraph0300

[16]CurrentPatentAssignee:ALKERMESPLC-US2019/241524,2019,A1Locationinpatent:Paragraph2408;2523-2524

[17]CurrentPatentAssignee:THEJOHNSHOPKINSUNIVERSITY-WO2020/215094,2020,A1Locationinpatent:Page/Pagecolumn236;237

[18]CurrentPatentAssignee:VINCEREBIOSCIENCES-WO2022/192562,2022,A1Locationinpatent:Paragraph00487-00488

[1]CurrentPatentAssignee:KRONOSBIOINC-US2015/175616,2015,A1Locationinpatent:Paragraph0283;0285

[2]CurrentPatentAssignee:KRONOSBIOINC-WO2015/100217,2015,A1Locationinpatent:Page/Pagecolumn119

[3]CurrentPatentAssignee:KRONOSBIOINC-WO2016/10809,2016,A1Locationinpatent:Paragraph0308

[4]CurrentPatentAssignee:GILEADSCIENCESINC-US2016/96827,2016,A1Locationinpatent:Paragraph1110;1111

[5]CurrentPatentAssignee:KRONOSBIOINC-WO2016/172117,2016,A1Locationinpatent:Page/Pagecolumn49

[1]CurrentPatentAssignee:PFIZERINC-US2015/361067,2015,A1Locationinpatent:Paragraph0600

[2]Kung,Pei-Pei;Bingham,Patrick;Brooun,Alexei;Collins,Michael;Deng,Ya-Li;Dinh,Dac;Fan,Connie;Gajiwala,KetanS.;Grantner,Rita;Gukasyan,HovhannesJ.;Hu,Wenyue;Huang,Buwen;Kania,Robert;Kephart,SusanE.;Krivacic,Cody;Kumpf,RobertA.;Khamphavong,Penney;Kraus,Manfred;Liu,Wei;Maegley,KarenA.;Nguyen,Lisa;Ren,Shijian;Richter,Dan;Rollins,RobertA.;Sach,Neal;Sharma,Shikhar;Sherrill,John;Spangler,Jillian;Stewart,AlbertE.;Sutton,Scott;Uryu,Sean;Verhelle,Dominique;Wang,Hui;Wang,Shuiwang;Wythes,Martin;Xin,Shuibo;Yamazaki,Shinji;Zhu,Huichun;Zhu,Jinjiang;Zehnder,Luke;Edwards,Martin[JournalofMedicinalChemistry,2018,vol.61,#3,p.650-665]

[1]CurrentPatentAssignee:YUMANITYTHERAPEUTICSINC-WO2017/112853,2017,A1Locationinpatent:Paragraph0185

[2]CurrentPatentAssignee:YUMANITYTHERAPEUTICSINC-WO2016/105485,2016,A2Locationinpatent:Paragraph0212

[3]Degnan,AndrewP.;Maxwell,Darrell;Balakrishnan,Anand;Brown,JeffreyM.;Easton,Amy;Gulianello,Michael;Hanumegowda,Umesh;Hill-Drzewi,Melissa;Miller,Regina;Santone,KennethS.;Senapati,Arun;Shields,EricE.;Sivarao,DigavalliV.;Westphal,Ryan;Whiterock,ValerieJ.;Zhuo,Xiaoliang;Bronson,JoanneJ.;Macor,JohnE.[BioorganicandMedicinalChemistryLetters,2016,vol.26,#24,p.5871-5876]

[4]CurrentPatentAssignee:CASEWESTERNRESERVEUNIVERSITY-WO2021/2986,2021,A2Locationinpatent:Paragraph00203

[5]CurrentPatentAssignee:SCHROEDINGERLLC-WO2022/164789,2022,A1Locationinpatent:Page/Pagecolumn357-358

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1305207-52-6 Molecular Formula|1305207-52-6 MDL|1305207-52-6 SMILES|1305207-52-6 Oxetane-3-carbaldehyde